Seeking Alpha

Cardinal Health (CAH +1.6%) puts up a decent FQ2 report this morning, despite weaker revenue out...

Cardinal Health (CAH +1.6%) puts up a decent FQ2 report this morning, despite weaker revenue out of its pharmaceutical unit, due in part to brand-to-generic conversions and the loss of the Express Scripts business. Net earnings still managed to rise by 16% Y/Y however, as the drug wholesaler posted better margins. Revenue in its pharmaceutical business its largest by revenue, declined 8%, while its medical business increased by 3%, boosted by last year's acquisition of FutureMed and an additional sales day.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)